Ocular Photography - External (L34393)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Comprehensive Pediatric Eye and Vision Examination
Guideline Brief 2017 EVIDENCE-BASED CLINICAL PRACTICE GUIDELINE COMPREHENSIVE PEDIATRIC EYE AND VISION EXAMINATION OVERVIEW TOPICS The American Optometric Association (AOA) convened an expert panel to develop a new evidence-based guideline that recommends annual comprehensive eye exams for children. This guideline is intended to help educate caregivers and ensure doctors of optometry are empowered to provide the best care for their young patients. With this guideline, parents and other healthcare professionals know which tests and interventions are proven to optimize a child’s eye care and the frequency with which children should receive a comprehensive eye exam to ensure their visual health. 1 1. AN EPIDEMIC OF UNDIAGNOSED EYE AND VISION PROBLEMS Children play and learn to develop skills needed for a successful life. If their eyes have problems or their vision is limited – as is the case with at least 25 percent of school-age 1 IN 5 PRESCHOOLERS children – their ability to participate in sports, learn in school, and observe the world around them may be significantly impaired and they can easily fall behind their peers. HAVE VISION PROBLEMS, AND BY THE TIME THEY Further evidence is provided in the Health and Medicine Division of the National Acade- mies of Sciences, Engineering, and Medicine (NASEM) report. ENTER SCHOOL, 25% WILL NEED OR WEAR Eyes mature even as a fetus develops, and the rapid changes a child goes through in CORRECTIVE LENSES the first six years of life are critical in the development of good eyesight. This same time frame represents a “vulnerability” period – one in which children are most susceptible to harmful vision changes. -
Comprehensive Pediatric Eye and Vision Examination
American Optometric Association – Peer/Public Review Document 1 2 3 EVIDENCE-BASED CLINICAL PRACTICE GUIDELINE 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Comprehensive 18 Pediatric Eye 19 and Vision 20 Examination 21 22 For Peer/Public Review May 16, 2016 23 American Optometric Association – Peer/Public Review Document 24 OPTOMETRY: THE PRIMARY EYE CARE PROFESSION 25 26 The American Optometric Association represents the thousands of doctors of optometry 27 throughout the United States who in a majority of communities are the only eye doctors. 28 Doctors of optometry provide primary eye care to tens of millions of Americans annually. 29 30 Doctors of optometry (O.D.s/optometrists) are the independent primary health care professionals for 31 the eye. Optometrists examine, diagnose, treat, and manage diseases, injuries, and disorders of the 32 visual system, the eye, and associated structures, as well as identify related systemic conditions 33 affecting the eye. Doctors of optometry prescribe medications, low vision rehabilitation, vision 34 therapy, spectacle lenses, contact lenses, and perform certain surgical procedures. 35 36 The mission of the profession of optometry is to fulfill the vision and eye care needs of the 37 public through clinical care, research, and education, all of which enhance quality of life. 38 39 40 Disclosure Statement 41 42 This Clinical Practice Guideline was funded by the American Optometric Association (AOA), 43 without financial support from any commercial sources. The Evidence-Based Optometry 44 Guideline Development Group and other guideline participants provided full written disclosure 45 of conflicts of interest prior to each meeting and prior to voting on the strength of evidence or 46 clinical recommendations contained within this guideline. -
Chronic Conjunctivitis
9/8/2017 Allergan Pharmaceuticals Speaker’s Bureau Bio-Tissue BioDLogics, LLC Katena/IOP Seed Biotech COA Monterey Symposium 2017 Johnson and Johnson Vision Care, Inc. Shire Pharmaceuticals Nicholas Colatrella, OD, FAAO, Dipl AAO, ABO, ABCMO Jeffrey R. Varanelli, OD, FAAO, Dipl ABO, ABCMO Text NICHOLASCOLA090 to 22333 to join Live Text Poll Nicholas Colatrella, OD, FAAO, Dipl AAO, Jeffrey Varanelli, OD, FAAO, Dipl ABO, ABO, ABCMO ABCMO Text NICHOLASCOLA090 to 22333 once to join Then text A, B, C, D, E or write in your answer Live Immediate Accurate Chronic conjunctivitis is one of the most frustrating reasons that patients present to the office (1) Time course Often times patients will seek multiple providers searching for a solution The chronicity of their symptoms is extremely frustrating to the (2) Morphology patient and treating physician alike Some conditions can seriously affect vision and create ocular morbidity (3) Localization of disease process Many of these diseases do not respond to commonly used topical antibiotics, topical steroids, artificial tears, and other treatments for external ocular disease (4) Type of discharge or exudate Our hope during this one-hour lecture is to present a process to help aid in the diagnosis of chronic conjunctivitis help you determine the most likely etiology 1 9/8/2017 Three weeks is the dividing point as it is the upper limit for cases of viral infection and most bacterial infections to resolve without treatment. Acute Conjunctivitis Conjunctivitis that has been present for less than 3 weeks -
Vertical Perspective Medical Assistance Program
Kansas Vertical Perspective Medical Assistance Program December 2006 Provider Bulletin Number 688 General Providers Emergent and Nonemergent Diagnosis Code List Attached is a list of diagnosis codes and whether the Kansas Medical Assistance Program (KMAP) considers the code to be emergent or nonemergent. Providers are responsible for validating whether a particular diagnosis code is covered by KMAP under the beneficiary’s benefit plan and that all program requirements are met. This list does not imply or guarantee payment for listed diagnosis codes. Information about the Kansas Medical Assistance Program as well as provider manuals and other publications are on the KMAP Web site at https://www.kmap-state-ks.us. If you have any questions, please contact the KMAP Customer Service Center at 1-800-933-6593 (in-state providers) or (785) 274-5990 between 7:30 a.m. and 5:30 p.m., Monday through Friday. EDS is the fiscal agent and administrator of the Kansas Medical Assistance Program for the Kansas Health Policy Authority. Page 1 of 347 Emergency Indicators as noted by KMAP: N – Never considered emergent S – Sometimes considered emergent (through supporting medical documentation) Y – Always considered emergent Diagnosis Emergency Diagnosis Code Description Code Indicator 0010 Cholera due to Vibrio Cholerae S 0011 Cholera due to Vibrio Cholerae El Tor S 0019 Unspecified Cholera S 019 Late Effects of Tuberculosis N 0020 Typhoid Fever S 0021 Paratyphoid Fever A S 0022 Paratyphoid Fever B S 0023 Paratyphoid Fever C S 024 Glanders Y 025 Melioidosis -
ANTERIOR SEGMENT TREATMENT LADDERS Guidance for Greater Glasgow & Clyde Community Optometrists
ANTERIOR SEGMENT TREATMENT LADDERS Guidance for Greater Glasgow & Clyde Community Optometrists This guidance has been produced by the ‘Optometry Prescribing & Supply Group’* and should be considered in context with the overall prescribing framework advice document for Greater Glasgow & Clyde Optometrists *Frank Munro (Independent Prescribing Optometrist), Hugh Russell (Independent Prescribing Optometrist), William Wilkie (Chair, Lead Optometrist Group), Edward McVey (Optometric Adviser), Pamela McIntyre (Prescribing Lead), Mantej Chahal (Prescribing Adviser), Lorna Kelly (Head of Primary Care) Anterior Segment Treatment Ladders – NHS GG&C – December 2018 Guidance for GG&C Community Optometrists This document forms part of the overarching prescribing framework document for all prescribing optometrists within the Greater Glasgow and Clyde NHS Board area. The number of IP optometrists within GG&C is increasing year on year and once a request is made to the Board, all IP qualified optometrists are issued with an NHS prescribing pad. GG&C has developed a prescribing formulary based to improve safety within the prescribing community. It is hoped that the Optometry prescribing Framework, including documents such as this will help clinicians conform more closely with the GG&C formulary. This guidance provides safe, practical advice for the management of a number of common anterior eye conditions and is built on current guidance from the College of Optometrists and prescribing experience across Scotland. The guidance has been set up to follow the natural history of each condition and how a stepped approach should look on paper that would provide a role for all practice staff in the detection, treatment and management of these conditions. The treatment ladder approach provides a measured, evidence based, graded approach to the management of various anterior eye conditions. -
Diagnosis and Treatment of Neurotrophic Keratopathy
An Evidence-based Approach to the Diagnosis and Treatment of Neurotrophic Keratopathy ACTIVITY DIRECTOR A CME MONOGRAPH Esen K. Akpek, MD This monograph was published by Johns Hopkins School of Medicine in partnership Wilmer Eye Institute with Catalyst Medical Education, LLC. It is Johns Hopkins School of Medicine not affiliated with JAMA medical research Baltimore, Maryland publishing. Visit catalystmeded.com/NK for online testing to earn your CME credit. FACULTY Natalie Afshari, MD Mina Massaro-Giordano, MD Shiley Eye Institute University of Pennsylvania School of Medicine University of California, San Diego Philadelphia, Pennsylvania La Jolla, California Nakul Shekhawat, MD, MPH Sumayya Ahmad, MD Wilmer Eye Institute Mount Sinai School of Medicine Johns Hopkins School of Medicine New York, New York Baltimore, Maryland Pedram Hamrah, MD, FRCS, FARVO Christopher E. Starr, MD Tufts University School of Medicine Weill Cornell Medical College Boston, Massachusetts New York, New York ACTIVITY DIRECTOR FACULTY Esen K. Akpek, MD Natalie Afshari, MD Mina Massaro-Giordano, MD Professor of Ophthalmology Professor of Ophthalmology Professor of Clinical Ophthalmology Director, Ocular Surface Diseases Chief of Cornea and Refractive Surgery University of Pennsylvania School and Dry Eye Clinic Vice Chair of Education of Medicine Wilmer Eye Institute Fellowship Program Director of Cornea Philadelphia, Pennsylvania Johns Hopkins School of Medicine and Refractive Surgery Baltimore, Maryland Shiley Eye Institute Nakul Shekhawat, MD, MPH University of California, -
Outcomes of Vitrectomy for Retinal Detachment in a Patient with Ehlers
Lumi et al. J Med Case Reports (2021) 15:249 https://doi.org/10.1186/s13256-021-02855-w CASE REPORT Open Access Outcomes of vitrectomy for retinal detachment in a patient with Ehlers–Danlos syndrome type IV: a case report Xhevat Lumi1*, Gaber Bergant2, Anila Lumi1 and Mina Mahnic1 Abstract Background: The Ehlers–Danlos syndrome (EDS) is a group of connective tissue disorders characterized by fragile blood vessels and an increased tendency for bleeding and scarring. Here, we report the outcome of a pars plana vitrectomy for the treatment of rhegmatogenous retinal detachment in a patient with EDS type IV (vascular type). Case presentation: A 40-year-old Slovenian man with high myopia, unilateral bullous retinal detachment, and vitre- ous hemorrhage was referred for surgery. The patient had a history of colon perforation, muscle and arterial rupture in both lower limbs, and recurrent shoulder joint luxations. Genetic testing revealed a pathogenic mutation in the COL3A1 gene. The patient underwent a 25-gauge three-port pars plana vitrectomy. The tendency for bleeding during surgery was prevented by endodiathermy applied to the edges of the retinal breaks. Endolaser photocoagulation was performed under air. The surgical procedure was completed with the injection of gas tamponade, followed by the patient remaining for a few days in a face-down position. Mild postoperative vitreous hemorrhage was resorbed in frst week after the surgery. Postoperative extensive pigment dispersion on the posterior lens face persisted for several weeks. After the gas tamponade had resorbed, the retina was fat and remained attached during the follow-up period. -
Ablution Exercise – May Prevent Dacryocystitis
December 2019/ Vol 4/ Issue 8 Print ISSN : 2581-4907, Online ISSN : 2456-6454 Original Research Article Ablution exercise – may prevent dacryocystitis Pandey J. 1, Ranjan A .2 , Gupta R.C. 3, Khan P. 4 1Dr. Jayati Pandey, Senior Resident, 2Dr. Alok Ranjan, Senior Resident, 3Dr. Ramesh Chandra Gupta, Principal, LLRM Medical College, Meerut. Ex-HOD Department of Ophthalmology, 4Dr. Perwez Khan, Professor & Head; all authors are affiliated with Department of Ophthalmology, G.S.V.M Medical College, Kanpur, Uttar Pradesh, India. Corresponding Author: Dr. Jayati Pandey, Senior Resident, Department of Ophthalmology, G.S.V.M Medical College, Kanpur, Uttar Pradesh, India. Email: [email protected] ……………………………………………………………………………………………………………………………………... Abstract Background: Dacryocystitis is an infection and inflammation of the lacrimal sac and most common cause of ocular morbidity in India. It’s accounting for 87.1% of epiphora and causes social discomfort due to continuous watering from the eyes. It is more common in India as being tropical country. It has higher incidence among lower socioeconomic status. Hygiene plays an important role in its aetiology. Objective: This study was aimed to survey the demographic characteristics of patients received external dacryocystorhinostomy (DCR) surgery to correlate with religious aspect of the patients. Material & Methods : The present study is a retrospective study conducted at Ophthalmology Department from the hospital records of patients who underwent external DCR for epiphora from January 2013 to December 2017. Results: Out of 305 cases underwent DCR (n=305), maximum (n=179, 58.69%) were above the age of 40 years out of which maximum were in age group of 41-50 years (n=78, 24.57%), majority of them were females 70.49% (n=215) with males being only 29.51% (n=90). -
Cornea/External Disease 2017-2019
Academy MOC Essentials® Practicing Ophthalmologists Curriculum 2017–2019 Cornea/External Disease *** Cornea/External Disease 2 © AAO 2017-2019 Practicing Ophthalmologists Curriculum Disclaimer and Limitation of Liability As a service to its members and American Board of Ophthalmology (ABO) diplomates, the American Academy of Ophthalmology has developed the Practicing Ophthalmologists Curriculum (POC) as a tool for members to prepare for the Maintenance of Certification (MOC) -related examinations. The Academy provides this material for educational purposes only. The POC should not be deemed inclusive of all proper methods of care or exclusive of other methods of care reasonably directed at obtaining the best results. The physician must make the ultimate judgment about the propriety of the care of a particular patient in light of all the circumstances presented by that patient. The Academy specifically disclaims any and all liability for injury or other damages of any kind, from negligence or otherwise, for any and all claims that may arise out of the use of any information contained herein. References to certain drugs, instruments, and other products in the POC are made for illustrative purposes only and are not intended to constitute an endorsement of such. Such material may include information on applications that are not considered community standard, that reflect indications not included in approved FDA labeling, or that are approved for use only in restricted research settings. The FDA has stated that it is the responsibility of the physician to determine the FDA status of each drug or device he or she wishes to use, and to use them with appropriate patient consent in compliance with applicable law. -
The Red Eye the Eye Newsletter • Volume Xix • Spring, 2007 Robert M
THE RED EYE THE EYE NEWSLETTER • VOLUME XIX • SPRING, 2007 ROBERT M. SCHARF, M.D. • (972) 596-3328 All red eyes are not the same. This is why a red eye has to be seen to be treated. The eye is a very complex organ and will show a The space between the conjunctiva lining the globe response to an irritation by becoming red. There are a very and the conjunctiva on the large number of disorders that can cause the eye to become back side of the eyelid. red. The redness is actually dilation of the conjunctival Cornea vessels. The conjunctiva is a blood vessel-containing, clear Iris layer of tissue that overlies the white sclera of the eye. The Lens conjunctiva can become red when it is affected directly as Conjunctiva in pink eye or when one of its neighbors is irritated. These Limbus neighbors include, the eyelids themselves, the skin of the Eyelashes eyelids, the eyelashes, the border of the eyelid (eyelid margin), the sclera and episclera, the cornea, the iris, the Sclera lens, the globe, and the orbit. Fig. A This newsletter will list many, but not all, of the Iris seen through clear cornea wide variety of disorders that can cause a red eye, the anatomy Clear conjunctiva of the affected parts of the eye (Figures A, B, C), and a overlying white sclera brief description of several of the disorders. The asterisk Limbus graphic is a line drawing of the companion color photo. Conjunctiva Fig. B Allergic conjunctivitis. The external eye is under con- stant immunological challenge from a wide variety of substances, which may lead to the development of one of many conditions that can be loosely grouped together as allergic eye disease. -
Ocular Hazards of UV Exposure
Human Performance Briefing Leaflet 19HUPBL06 11 December 2019 Ocular Hazards of UV Exposure Please note: This paper supersedes 09MEDBL06 - Ocular Hazards of UV Exposure INTRODUCTION The range of wavelengths of visible light is from approximately 400 nanometers (nm) to 700nm. The wavelength of UV radiation is below that of visible light, ranging from 100nm to 400 nm. Since UV radiation has more energy than visible light it may cause damage to the ocular lens of the eye causing cataracts. It is believed to play a role in the pathophysiology of macular degeneration. Ultraviolet radiation is divided into 3 major component bands: UV-A, UV-B, and UV-C. • UV-A radiation comprises longer wavelength radiation, close to blue in the visible spectrum. It is usually responsible for skin tanning and browning in addition to premature aging of the skin with prolonged exposure. • UV-B radiation comprises shorter wavelength radiation. It can cause blistering sunburn and is believed to be associated with skin cancer. • UV-C radiation is absorbed by the atmosphere and is neither detected at sea level nor at typical flight levels. If adequate eye protection is not worn; excessive exposure to intense sunlight and/or to any artificial source of light, such as welding torches and sun lamps, can lead to burning of the delicate tissue in the eye. The highest risk comes from direct exposure to sunlight, light reflected from snow and snow- covered surfaces, or when flying above clouds with light reflected from cloud surfaces. The retina is mostly spared the harmful effects of UV because this part of the Electromagnetic (EM) spectrum is absorbed by the front part of the eye. -
Why Chain Length of Hyaluronan in Eye Drops Matters
diagnostics Review Why Chain Length of Hyaluronan in Eye Drops Matters Wolfgang G.K. Müller-Lierheim CORONIS Foundation, 81241 Munich, Germany; [email protected] Received: 21 June 2020; Accepted: 20 July 2020; Published: 23 July 2020 Abstract: The chain length of hyaluronan (HA) determines its physical as well as its physiological properties. Results of clinical research on HA eye drops are not comparable without this parameter. In this article methods for the assessment of the average molecular weight of HA in eye drops and a terminology for molecular weight ranges are proposed. The classification of HA eye drops according 1 to their zero shear viscosity and viscosity at 1000 s− shear rate is presented. Based on the gradient of mucin MUC5AC concentration within the mucoaqueous layer of the tear film a hypothesis on the consequences of this gradient on the rheological properties of the tear film is provided. The mucoadhesive properties of HA and their dependence on chain length are explained. The ability of HA to bind to receptors on the ocular epithelial cells, and in particular the potential consequences of the interaction between HA and the receptor HARE, responsible for HA endocytosis by corneal epithelial cells is discussed. The physiological function of HA in the framework of ocular surface homeostasis and wound healing are outlined, and the influence of the chain length of HA on the clinical performance of HA eye drops is illustrated. The use of very high molecular weight HA (hylan A) eye drops as drug vehicle for the next generation of ophthalmic drugs with minimized side effects is proposed and its advantages elucidated.